肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

乳腺癌诊疗指南（2022年版）

2022-04-11 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

国家卫健委乳腺癌诊疗指南

为进一步规范我国乳腺癌诊疗行为，提高医疗机构乳腺癌诊疗水平，改善乳腺癌患者预后，保障医疗质量和医疗安全，特制定本指南。

中文标题：

乳腺癌诊疗指南（2022年版）

发布机构：

中华人民共和国国家卫生健康委员会

发布日期：

2022-04-11

简要介绍：

乳腺癌是女性常见的恶性肿瘤之一，发病率位居女性恶性肿瘤的首位，严重危害妇女的身心健康。目前，通过采用综合治疗手段，乳腺癌已成为疗效最佳的实体肿瘤之一。为进一步规范我国乳腺癌诊疗行为，提高医疗机构乳腺癌诊疗水平，改善乳腺癌患者预后，保障医疗质量和医疗安全，特制定本指南。

相关资料下载：
[AttachmentFileName(sort=1, fileName=乳腺癌诊疗指南+（2022年版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2d53a1c00250989b, title=乳腺癌诊疗指南（2022年版）, enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=0, author=, summary=为进一步规范我国乳腺癌诊疗行为，提高医疗机构乳腺癌诊疗水平，改善乳腺癌患者预后，保障医疗质量和医疗安全，特制定本指南。, cover=https://img.medsci.cn/Random/diagnostic-form-in-hospital-conceptual-image-7JAH3GT.jpg, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 11 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">乳腺癌是女性常见的恶性肿瘤之一，发病率位居女性恶性肿瘤的首位，严重危害妇女的身心健康。目前，通过采用综合治疗手段，乳腺癌已成为疗效最佳的实体肿瘤之一。为进一步规范我国乳腺癌诊疗行为，提高医疗机构乳腺癌诊疗水平，改善乳腺癌患者预后，保障医疗质量和医疗安全，特制定本指南。</span></p>, tagList=[TagDto(tagId=72213, tagName=国家卫健委), TagDto(tagId=440210, tagName=乳腺癌诊疗指南)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=21054, categoryName=梅斯医学-乳腺癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=285, articleKeyword=乳腺癌, articleKeywordNum=6, guiderKeywordId=308, guiderKeyword=诊疗指南, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18878, appHits=682, showAppHits=0, pcHits=2502, showPcHits=18195, likes=0, shares=95, comments=4, approvalStatus=1, publishedTime=Tue Jul 12 20:35:00 CST 2022, publishedTimeString=2022-04-11, pcVisible=1, appVisible=1, editorId=0, editor=lixiang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=lixiang, createdTime=Thu Jul 07 17:06:42 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 18:43:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=乳腺癌诊疗指南+（2022年版）.pdf)])
乳腺癌诊疗指南+（2022年版）.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2226357, encodeId=0571222635e23, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=655b8245725, createdName=ms6000000190242997, createdTime=Wed Sep 18 11:06:35 CST 2024, time=2024-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1232906, encodeId=c7cb12329062d, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 17 08:00:15 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232563, encodeId=94101232563f9, content=下载来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Fri Jul 15 06:01:14 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232078, encodeId=d5f712320e86b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Tue Jul 12 20:48:48 CST 2022, time=2022-07-12, status=1, ipAttribution=)]
    2024-09-18 ms6000000190242997 来自湖北省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2226357, encodeId=0571222635e23, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=655b8245725, createdName=ms6000000190242997, createdTime=Wed Sep 18 11:06:35 CST 2024, time=2024-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1232906, encodeId=c7cb12329062d, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 17 08:00:15 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232563, encodeId=94101232563f9, content=下载来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Fri Jul 15 06:01:14 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232078, encodeId=d5f712320e86b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Tue Jul 12 20:48:48 CST 2022, time=2022-07-12, status=1, ipAttribution=)]
    2022-07-17 海上飘星

    好好学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2226357, encodeId=0571222635e23, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=655b8245725, createdName=ms6000000190242997, createdTime=Wed Sep 18 11:06:35 CST 2024, time=2024-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1232906, encodeId=c7cb12329062d, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 17 08:00:15 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232563, encodeId=94101232563f9, content=下载来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Fri Jul 15 06:01:14 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232078, encodeId=d5f712320e86b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Tue Jul 12 20:48:48 CST 2022, time=2022-07-12, status=1, ipAttribution=)]
    2022-07-15 ms5000000275821148

    下载来学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2226357, encodeId=0571222635e23, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=655b8245725, createdName=ms6000000190242997, createdTime=Wed Sep 18 11:06:35 CST 2024, time=2024-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1232906, encodeId=c7cb12329062d, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 17 08:00:15 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232563, encodeId=94101232563f9, content=下载来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Fri Jul 15 06:01:14 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232078, encodeId=d5f712320e86b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Tue Jul 12 20:48:48 CST 2022, time=2022-07-12, status=1, ipAttribution=)]
    2022-07-12 ms2000000529313829

    学习

    0

拓展阅读

Radiology：深度学习算法在钼靶乳腺癌筛查检测中的应用

研究表明，与医师相比，DL算法作为单个医师的性能并不差。结果很有希望，深度学习算法可以在保持相同阅读标准的情况下取代双重阅读程序中的一个医师，并有可能通过检测不同的癌症来提高癌症的早期检测。

乳腺癌Nottingham组织学分级系统（Nottingham Grading System，NGS)

乳腺癌Nottingham组织学分级系统（Nottingham Grading System，NGS)

Radiology：弥散MRI预测乳腺癌分子亚型和对新辅助化疗治疗反应的能力及价值

扩散加权成像是一种广泛使用的成像技术，通过使用不同的扩散权（称为q空间）来描述生物组织中限制性水扩散的行为，在乳腺癌亚型的无创表征和肿瘤治疗的早期病理变化检测中显示出潜力。

【论著】| 基于机器学习构建乳腺癌骨转移预测模型

本研究选择9种机器学习算法探索建立有效的预测模型，并对模型评估对比，寻找更适合构建乳腺癌骨转移预测模型的方法。

【论著】| Circ-0007766作为miR-1972海绵调控HER2表达促进乳腺癌细胞迁移和侵袭

本研究旨在探讨Circ-0007766作为miR-1972海绵调控HER2表达对乳腺癌细胞迁移和侵袭的影响。

早期乳腺癌术后MRD监测早期识别复发，阳性预测值100%

本研究表明，在复发患者中，PCM 检测到 ctDNA 阳性比临床复发提前很多，表现出与无复发生存期的强相关性，可用于识别复发风险高的患者，进行早期干预。

2022 BAD/BPG指南：窄谱中波紫外线光疗

英国皮肤科医师协会(BAD,British Association of Dermatologists) · 2022-05-23

2020 ECCO/ESPGHAN指南：儿童克罗恩病的药物治疗

欧洲克罗恩病和结肠炎组织(ECCO,European Cron&#039;s and Colitis Organisation) · 2020-10-07

中国乳腺癌筛查与早期诊断指南

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2022-04-28

2020 AAO指南：成人眼科综合评估

美国眼科学会(AAO,American Academy of Ophthalmology) · 2020-11-30

疟疾诊疗指南

浙江大学医学院附属第一医院 · 2022-07-29

ESC和ACC/AHA/HFSA心力衰竭指南的建议之间的头对头比较

欧洲心脏病学会(ESC,European Society of Cardiology) · 2022-08-25